FI942392A - Peptidejä ja vasta-aineita nivelreuman hoitoon - Google Patents

Peptidejä ja vasta-aineita nivelreuman hoitoon Download PDF

Info

Publication number
FI942392A
FI942392A FI942392A FI942392A FI942392A FI 942392 A FI942392 A FI 942392A FI 942392 A FI942392 A FI 942392A FI 942392 A FI942392 A FI 942392A FI 942392 A FI942392 A FI 942392A
Authority
FI
Finland
Prior art keywords
peptides
antibodies
treatment
joint inflammation
necessarily adjacent
Prior art date
Application number
FI942392A
Other languages
English (en)
Swedish (sv)
Other versions
FI942392A0 (fi
Inventor
Julian Kirby
Ian Victor Lewin
Sarita Maman
Denis Raymond Stanworth
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of FI942392A publication Critical patent/FI942392A/fi
Publication of FI942392A0 publication Critical patent/FI942392A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI942392A 1991-11-25 1994-05-24 Peptidejä ja vasta-aineita nivelreuman hoitoon FI942392A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919125024A GB9125024D0 (en) 1991-11-25 1991-11-25 Rheumatoid arthritus treatment
PCT/GB1992/002174 WO1993011153A1 (en) 1991-11-25 1992-11-25 Peptides and antibodies for treatment of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
FI942392A true FI942392A (fi) 1994-05-24
FI942392A0 FI942392A0 (fi) 1994-05-24

Family

ID=10705197

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942392A FI942392A0 (fi) 1991-11-25 1994-05-24 Peptidejä ja vasta-aineita nivelreuman hoitoon

Country Status (10)

Country Link
EP (1) EP0614464B1 (fi)
JP (1) JPH07507045A (fi)
AT (1) ATE163939T1 (fi)
AU (2) AU2951392A (fi)
CA (1) CA2123694A1 (fi)
DE (1) DE69224750D1 (fi)
ES (1) ES2112921T3 (fi)
FI (1) FI942392A0 (fi)
GB (2) GB9125024D0 (fi)
WO (1) WO1993011153A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416865D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of inflammatory diseases of the gastro-intestinal tract
GB9416864D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of IgA nephropathy
ES2190799T5 (es) 1996-03-01 2008-08-16 Novartis Ag Inmunogenos peptidicos para vacunacion y tratamiento contra la alergia.
AU2001270098A1 (en) * 2000-06-22 2002-01-02 San Diego State University Foundation Recombination modulators and methods for their production and use
AU2009262199B2 (en) 2008-06-27 2012-08-09 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
US4692511A (en) * 1984-07-03 1987-09-08 Immunetech Pharmaceuticals Peptide antagonists for the C5a anaphylatoxin
EP0235391B1 (en) * 1985-12-26 1992-06-10 The University of Saskatchewan Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
GB8616174D0 (en) * 1986-07-02 1986-08-06 Antibody Technology Ltd Monoclonal antibodies
DK268889A (da) * 1988-06-07 1989-12-08 Smithkline Beckman Corp Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
EP0346022B1 (en) * 1988-06-10 1996-02-14 United Biomedical, Inc. Peptide fragments of HIV
FR2646425B1 (fr) * 1989-04-26 1991-08-30 Neosystem Sa Peptides synthetiques du conjugue de l'ubiquitine et de l'histone h2a
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
WO1991019001A1 (en) * 1990-05-25 1991-12-12 British Technology Group Ltd Immunodiagnostic assay for rheumatoid arthritis
CA2060699A1 (en) * 1991-02-11 1992-08-12 Isia Bursuker Gm-csf inhibiting oligopeptides

Also Published As

Publication number Publication date
EP0614464B1 (en) 1998-03-11
AU7196596A (en) 1997-02-06
JPH07507045A (ja) 1995-08-03
ATE163939T1 (de) 1998-03-15
CA2123694A1 (en) 1993-06-10
ES2112921T3 (es) 1998-04-16
WO1993011153A1 (en) 1993-06-10
FI942392A0 (fi) 1994-05-24
GB2261665B (en) 1995-11-08
DE69224750D1 (de) 1998-04-16
GB9125024D0 (en) 1992-01-22
AU2951392A (en) 1993-06-28
EP0614464A1 (en) 1994-09-14
GB9224684D0 (en) 1993-01-13
GB2261665A (en) 1993-05-26

Similar Documents

Publication Publication Date Title
DE3585556D1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
ATE442159T1 (de) Parathyroidhormon analoge
SE9100799D0 (sv) Recombinant human factor viii derivatives
DE69129865D1 (de) Osteogene peptide
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
DE59004445D1 (de) Arzneimittel (calcitoningen verwandte peptide) zur behandlung erektiler dysfunktionen.
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DE69525544T2 (de) Peptidanaloga des menschlichen myelinbasischen proteins mit substitution in position 91 zur behandlung von multipler sklerose
ES2174770T1 (es) Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
SE9403526D0 (sv) New Peptides
DE68927379D1 (de) Plättchen blockierende peptide
BR9306272A (pt) Peptídeo e composiçao farmacêutica
FI942392A (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
DE3586979D1 (de) Neue zns-aktive peptide mit wirkung auf das cholinerge system.
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
FI964363A (fi) Peptidejä
DE69027542T2 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
DK262986A (da) Peptidmateriale med thymushumoral aktivitet
ATE25984T1 (de) Pharmakologisch aktive peptide.
DK34590A (da) Biologisk aktive molekyler
ATE92078T1 (de) Pharmakologisch aktive peptide.
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
YU64192A (sh) Analozi insulina
ES2080326T3 (es) Proteinas similares a ancrod, su obtencion y empleo.